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Background
Studies have suggested that selective microbial targets
prevail in the fecal microbiota of infants with eczema.
This study aims to evaluate and compare the composi-
tion of fecal microbiota of infants who developed
eczema by 2 years of age and healthy controls.
Methods
Children with eczema at 2 years old (n=26) and their
matched (for gender, mode of delivery and feeding in
first 6 months) healthy controls (n=26) were selected
from the placebo group of a cohort of at-risk infants
participating in an randomized double-blind placebo
controlled trial on the protective effects of supplemental
probiotics (first 6 months) on eczema and allergies.
Children with eczema were subclassified into atopic
eczema (n=12) and non-atopic eczema (n=14). Molecular
evaluation of fecal microbiota were conducted using
Fluorescence In Situ Hybridization-Flow Cytometry
(FISH-FC) for fecal samples collected at 3 days, 1, 3, and
12 months. Probes were selected to target Eubacterium
rectale-Clostridium coccoides group (Erec482), Clostri-
dium leptum subgroup (Clep866 and the corresponding
competitor probes), Bacteroides-Prevotella group
(Bac303), Bifidobacterium genus (Bif164), Atopobium
group (Ato291), Lactobacilli- Enterococci group (Lab158),
Enterobacteriaceae family (Enter1432) and Clostridium
perfringens (Cperf191). Linear mixed model was used to
evaluate the longitudinal differences (i.e. 4 time points) of
bacterial targets while adjusting for gender, mode of
delivery, feeding up to 6 months, and allergic rhinitis and
wheezing within the eczema group at 2 years of age.
Results
Longitudinal analyses over four time points showed that
higher relative abundance of Enterobacteriaceae [coeffi-
cient (B): 1.104, 95% confidence interval (CI):0.175-2.033,
adj p=0.022] in children with eczema by 2 years of age.
Similar observations were made when eczema group was
subanalyzed into non-atopic and atopic eczema, where
higher relative abundance of Enterobacteriaceae [B:1.357,
95%CI; 0.382-2.332, adj p=0.008] and [B:1.165, 95%CI;
0.221-2.109, adj p=0.019] were observed respectively as
compared to healthy controls. Relative abundance of Clos-
tridium perfringens were also higher when subanalyzed for
non-atopic [B:0.572, 95%CI; 0.0009-1.144, adj p=0.050]
and atopic eczema [B:0.000451, 95%CI: 0.0001-0.0007,
adj p=0.012] compared to healthy controls.
Conclusions
Our data suggests that relative abundance of selective
microbial targets particularly Enterbacteriaceaea and
Clostridium perfringens in the fecal microbiota of infants
influence the development of eczema in early childhood.
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